Regulation of Nuclear Factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis?

The nuclear factor-kappaB (NF-κB) signaling pathway is considered as a potential therapeutic target in cancer therapy. It has been well established that transcription factor NF-κB is involved in regulating physiological and pathological events including inflammation, immune response and differentiat...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Cancer letters Ročník 509; s. 63 - 80
Hlavní autoři:	Mirzaei, Sepideh, Zarrabi, Ali, Hashemi, Farid, Zabolian, Amirhossein, Saleki, Hossein, Ranjbar, Adnan, Seyed Saleh, Seyed Hesam, Bagherian, Morteza, Sharifzadeh, Seyed omid, Hushmandi, Kiavash, Liskova, Alena, Kubatka, Peter, Makvandi, Pooyan, Tergaonkar, Vinay, Kumar, Alan Prem, Ashrafizadeh, Milad, Sethi, Gautam
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Ireland Elsevier B.V 01.07.2021 Elsevier Limited
Témata:	3' Untranslated regions Angiogenesis Apoptosis Breast cancer Cancer Cancer therapies Carcinogenesis Cell cycle Cell migration Cell proliferation Chemoresistance Chemotherapy Circular RNA Drug resistance Genes Immune response Immunotherapy Inflammation Kinases Long non-coding RNAs Malignancy Medical prognosis Metastases Metastasis MicroRNAs miRNA NF-κB protein Non-coding RNA Nuclear factor-kappaB (NF-κB) Ovarian cancer Phosphorylation Physiology Proteins Radiation therapy Radioresistance RNA polymerase Signal transduction Tumor necrosis factor-TNF Tumorigenesis Long non-coding RNAs Nuclear factor-kappaB (NF-κB) MicroRNAs Chemoresistance Circular RNA Radioresistance Cancer
ISSN:	0304-3835, 1872-7980, 1872-7980
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Popis
Shrnutí:	The nuclear factor-kappaB (NF-κB) signaling pathway is considered as a potential therapeutic target in cancer therapy. It has been well established that transcription factor NF-κB is involved in regulating physiological and pathological events including inflammation, immune response and differentiation. Increasing evidences suggest that deregulated NF-κB signaling can enhance cancer cell proliferation, metastasis and also mediate radio-as well as chemo-resistance. On the contrary, non-coding RNAs (ncRNAs) have been found to modulate NF-κB signaling pathway under different settings. MicroRNAs (miRNAs) can dually inhibit/induce NF-κB signaling thereby affecting the growth and migration of cancer cells. Furthermore, the response of cancer cells to radiotherapy and chemotherapy may also be regulated by miRNAs. Regulation of NF-κB by miRNAs may be mediated via binding to 3/-UTR region. Interestingly, anti-tumor compounds can increase the expression of tumor-suppressor miRNAs in inhibiting NF-κB activation and the progression of cancers. Long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs) can also effectively modulate NF-κB signaling thus affecting tumorigenesis. It is noteworthy that several studies have demonstrated that lncRNAs and circRNAs can affect miRNAs in targeting NF-κB activation. They can act as competing endogenous RNA (ceRNA) thereby reducing miRNA expression to induce NF-κB activation that can in turn promote cancer progression and malignancy. •NF-ĸB acts as a potential regulator of inflammation and is abnormal expressed in tumor cells.•Long non-coding RNAs can regulate NF-ĸB signalling by diverse mechanisms in cancer progression/inhibition.•MicroRNAs can bind to 3/-UTR of NF-ĸB to modulate its activation, and thereby affecting tumorigenesis.•Long non-coding RNAs can regulate miRNA expression that may act as upstream mediators of NF-ĸB.
Bibliografie:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23
ISSN:	0304-3835 1872-7980 1872-7980
DOI:	10.1016/j.canlet.2021.03.025